CFS-F FX, A / CP 660, A

Hazard statements (CLP)

H317

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause an allergic skin reaction

Hazard pictograms

GHS07

Signal word

Warning

Contains

2-octyl-2H-isothiazol-3-one; Ethylenediamine, ethoxylated and propoxylated; Mixture of 5- chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one

Hazard statements

H317 - May cause an allergic skin reaction.

Precautionary statements

P280 - Wear protective gloves, protective clothing, eye protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component polyethylene glycol (25322-68-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 2-octyl-2H-isothiazol-3-one (26530-20-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Ethylenediamine, ethoxylated (25214-63-5) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Ethylenediamine, ethoxylated and propoxylated (26316-40-5) Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one (55965-84-9) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component polyethylene glycol (25322-68-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Ethylenediamine, ethoxylated (25214-63-5) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Ethylenediamine, ethoxylated and propoxylated (26316-40-5) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2-octyl-2H-isothiazol-3-one (26530-20-1) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one (55965-84-9) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) GHS07 Signal word (CLP) Warning Contains 2-octyl-2H-isothiazol-3-one; Ethylenediamine, ethoxylated and propoxylated; Mixture of 5- chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one Hazard statements (CLP) H317 - May cause an allergic skin reaction. Precautionary statements (CLP) P280 - Wear protective gloves, protective clothing, eye protection. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. 2.3. Other hazards Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component polyethylene glycol (25322-68-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 2-octyl-2H-isothiazol-3-one (26530-20-1) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Ethylenediamine, ethoxylated (25214-63-5) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Ethylenediamine, ethoxylated and propoxylated This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (26316-40-5) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII 2-methylisothiazol-3(2H)-one (55965-84-9) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component polyethylene glycol (25322-68-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Ethylenediamine, ethoxylated (25214-63-5) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Ethylenediamine, ethoxylated and propoxylated The substance is not included in the list established in accordance with Article 59(1) of (26316-40-5) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2-octyl-2H-isothiazol-3-one (26530-20-1) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and The substance is not included in the list established in accordance with Article 59(1) of 2-methylisothiazol-3(2H)-one (55965-84-9) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Name Product identifier Conc. Classification according to Regulation (EC) No. 1272/2008 [CLP] polyethylene glycol CAS-No.: 25322-68-3 25 – 40 Not classified substance with national workplace exposure limit(s) EC-No.: 500-038-2 (DE) REACH-no: 01-2119958801- 32 Ethylenediamine, ethoxylated CAS-No.: 25214-63-5 2,5 - <5 Eye Irrit. 2, H319 EC-No.: 500-035-6 REACH-no: 01-2119471485- 32 Ethylenediamine, ethoxylated and propoxylated CAS-No.: 26316-40-5 2,5 - <5 Eye Irrit. 2, H319 EC-No.: 500-047-1 Skin Sens. 1, H317 REACH-no: 01-2119471488- 26 2-octyl-2H-isothiazol-3-one CAS-No.: 26530-20-1 <0,0015 Acute Tox. 3 (Oral), H301 (ATE=100 substance with national workplace exposure limit(s) EC-No.: 247-761-7 mg/kg bodyweight) (DE) EC Index-No.: 613-112-00-5 Acute Tox. 3 (Dermal), H311 (ATE=300 mg/kg bodyweight) Acute Tox. 2 (Inhalation), H330 (ATE=0,05 mg/l/4h) Skin Corr. 1, H314 Eye Dam. 1, H318 Skin Sens. 1A, H317 Aquatic Acute 1, H400 (M=100) Aquatic Chronic 1, H410 (M=100) EUH071 Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and CAS-No.: 55965-84-9 <0,0015 Acute Tox. 3 (Oral), H301 (ATE=66 mg/kg 2-methylisothiazol-3(2H)-one EC Index-No.: 613-167-00-5 bodyweight) Acute Tox. 2 (Dermal), H310 (ATE=50 mg/kg bodyweight) Acute Tox. 2 (Inhalation), H330 (ATE=0,05 mg/l/4h) Acute Tox. 2 (Inhalation:dust,mist), H330 (ATE=0,05 mg/l/4h) Skin Corr. 1C, H314 Eye Dam. 1, H318 Skin Sens. 1A, H317 Aquatic Acute 1, H400 (M=100) Aquatic Chronic 1, H410 (M=100) EUH071 Specific concentration limits: Name Product identifier Specific concentration limits 2-octyl-2H-isothiazol-3-one CAS-No.: 26530-20-1 (0,0015 ≤ C ≤ 100) Skin Sens. 1A; H317 EC-No.: 247-761-7 EC Index-No.: 613-112-00-5 Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and